Peptide Industry advanced
Peptide Regulatory Approval Pathways
Navigating the regulatory pathways for peptide drug approval in major markets. This peptide or oligopeptide is studied for its biological activity, structure...
By Encyclopeptide Editorial | 1 min read
regulatory approval fda ema
Overview
Peptide drugs follow specific regulatory pathways that differ from small molecules and large biologics.
US Pathways
- NDA: New Drug Application for novel peptides
- ANDA: Abbreviated NDA for generic peptides
- 505(b)(2): Hybrid application using literature data
- BLA: For recombinant peptide biologics
European Pathways
- Centralized procedure: EMA approval for EU-wide marketing
- National procedure: Single-country approval
- Biosimilar pathway: For recombinant peptide follow-ons
Key Requirements
- Comprehensive CMC documentation
- Comparability studies for generics
- Immunogenicity assessment
- Clinical endpoint or bioequivalence studies
References
- Source: ENCP Peptide Database
- Category: Peptide Industry
Test Your Knowledge
Reinforce what you learned about Peptide Regulatory Approval Pathways with interactive quizzes on Wikipept.
Take a Quiz on Wikipept